Alpha‐blockers vs placeboAdverse events (4 weeks' to 180 days' · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 33 participantsGRADE not reported